Sanofi Drug Shows Promise Against Prostate Cancer

By: Marilynn Marchione / AP Medical Writer
By: Marilynn Marchione / AP Medical Writer

A study suggests that an experimental drug may modestly extend the lives of men with advanced prostate cancer who are no longer responding to other treatments.

The drug, cabazitaxel (kuh-BAH-zuh-TAX-uhl), helped men live an average of 10 weeks longer in a large study sponsored by the drug's maker, Sanofi-Aventis. Researchers hope the drug can make more of a difference in men who aren't so sick. The federal Food and Drug Administration has said it will give the drug fast review.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
8195 Front Beach Road Panama City Beach, FL 32407 Station: 850-234-7777 News: 850-230-5221 Fax: 850-233-6647 FCC Form 398
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 86332157